Briganti and colleagues concluded that, together with the main PROTEUS study, the substudy supports 1-year perioperative apalutamide plus ADT as a treatment option for patients with high-risk ...
The ex-wife of Donald Trump Jr, with whom she shares five children, announced in May that she had been diagnosed with breast cancer.
Amgen (NASDAQ:AMGN) presented Phase III data at the European Society for Medical Oncology Congress 2026 showing that its DLL3-targeting BiTE therapy IMDELLTRA, when added to durvalumab maintenance ...
Complex on MSN
Halle Berry's custody war drags into second week as ex gets restraining order extended
Olivier Martinez faced questions over a sworn 2024 statement as Halle Berry fought to restore shared custody of their 13-year ...
In the esports events at the 2026 Aichi-Nagoya Asian Games, there was a word heard just as often as news of the national team ...
FOURLIGHT-1 shows atirmociclib plus fulvestrant improved PFS to 9.4 vs 6.6 months after prior CDK4/6 inhibition in HR+/HER2− ...
An immunotherapy-based regimen combining durvalumab and the PARP inhibitor, olaparib, demonstrated encouraging long-term ...
Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use ...
Darolutamide Plus ADT and Radiotherapy in Very High-Risk Prostate Cancer / cancer, cancer care, Cancer research, cancer treatment, ...
Bristol Myers Squibb reported promising early MS CAR-T data (zola-cel) with 60 patients off medication, but disclosed one ...
Merck & Moderna to present positive results from phase 3 INTerpath-001 trial for intismeran autogene plus Keytruda at ESMO 2026 Presidential Symposium: Rahway, New Jersey Saturday ...
As Somalia strengthens its healthcare system, stroke deserves greater attention in public education, clinical services, research and national health planning. The message every Somali family should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results